Literature DB >> 20101269

Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.

Anil Kumar1, Beenta Kumari, Puneet Kumar.   

Abstract

OBJECTIVE: Cyclooxygenase isoenzyme is known to be expressed in different regions of brain, and is mainly used for the treatment of pain and inflammation. Recently, it is proposed that cyclooxygenase isoenzyme may also play a key role in the pathophysiology of various brain-related disorders. The present study was aimed to explore the protective effect of cyclooxygenase inhibitors on stress by using an animal model of chronic stress.
METHODS: The animals were forced to swim individually for a period of 6 min every day for 15 d. Then, the behavior (locomotor activity, anxiety and memory) and biochemical (lipid peroxidation, nitrite level, reduced glutathione, and catalase) alterations were assessed.
RESULTS: Forced swimming for 15 d caused impaired locomotor activity, anxiety-like behavior and decreased percentage of memory retention, as compared to naive mice (without chronic fatigue treatment). Biochemical analysis revealed significant increases in lipid peroxidation and nitrite level, while levels of reduced glutathione and catalase activity were both decreased. Chronic treatment with naproxen (14 mg/kg, i.p.), rofecoxib (5 mg/kg, i.p.), meloxicam (5 mg/kg, i.p.), nimesulide (5 mg/kg, i.p.) and valdecoxib (10 mg/kg, i.p.) significantly attenuated these behavioral and biochemical (oxidative damage) alterations in chronic-stressed mice.
CONCLUSION: The cyclooxygenase inhibitors could be used in the management of chronic fatigue-like conditions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101269      PMCID: PMC5560377          DOI: 10.1007/s12264-010-0713-x

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  58 in total

1.  Erythrocyte oxidative damage in chronic fatigue syndrome.

Authors:  Ross S Richards; Lexin Wang; Herbert Jelinek
Journal:  Arch Med Res       Date:  2006-11-03       Impact factor: 2.235

Review 2.  [Chronic fatigue syndrome--exercise and physical activity].

Authors:  Shai Greenberg; Mordechai Frid
Journal:  Harefuah       Date:  2006-04

3.  Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice.

Authors:  J Itoh; T Nabeshima; T Kameyama
Journal:  Eur J Pharmacol       Date:  1991-02-26       Impact factor: 4.432

4.  Ca(2+)-independent caspase-3 but not Ca(2+)-dependent caspase-2 activation induced by oxidative stress leads to SH-SY5Y human neuroblastoma cell apoptosis.

Authors:  Salvatore Amoroso; Angela D'Alessio; Rossana Sirabella; Gianfranco Di Renzo; Lucio Annunziato
Journal:  J Neurosci Res       Date:  2002-05-15       Impact factor: 4.164

5.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death.

Authors:  R M Sapolsky
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

6.  Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice.

Authors:  K Matsumoto; K Yobimoto; N T Huong; M Abdel-Fattah; T Van Hien; H Watanabe
Journal:  Brain Res       Date:  1999-08-21       Impact factor: 3.252

Review 7.  Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases.

Authors:  Luisa Minghetti
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

8.  Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson's disease.

Authors:  M B Mattammal; R Strong; V M Lakshmi; H D Chung; A H Stephenson
Journal:  J Neurochem       Date:  1995-04       Impact factor: 5.372

9.  Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice.

Authors:  Richa Goyal; Kumar Anil
Journal:  Pharmacol Rep       Date:  2007 May-Jun       Impact factor: 3.024

Review 10.  The HPA axis and the genesis of chronic fatigue syndrome.

Authors:  Anthony J Cleare
Journal:  Trends Endocrinol Metab       Date:  2004-03       Impact factor: 12.015

View more
  3 in total

1.  Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress.

Authors:  Anil Kumar; Barinder Singh; Jitendriya Mishra; Sangeeta Pilkhwal Sah; Raghavender Pottabathini
Journal:  Inflammopharmacology       Date:  2015-06-30       Impact factor: 4.473

2.  Chronic administration of parecoxib exerts anxiolytic-like and memory enhancing effects and modulates synaptophysin expression in mice.

Authors:  Bo Wang; Xin Jin; Xin Kuang; Shaowen Tian
Journal:  BMC Anesthesiol       Date:  2017-11-13       Impact factor: 2.217

3.  Hippocampal Over-Expression of Cyclooxygenase-2 (COX-2) Is Associated with Susceptibility to Stress-Induced Anhedonia in Mice.

Authors:  Tatyana Strekalova; Dmitrii Pavlov; Alexander Trofimov; Daniel C Anthony; Andrei Svistunov; Andrey Proshin; Aleksei Umriukhin; Alexei Lyundup; Klaus-Peter Lesch; Raymond Cespuglio
Journal:  Int J Mol Sci       Date:  2022-02-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.